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History of the World Allergy Organization: In 1951,
the leaders in allergy from all over the world came
together to form the International Association of Aller-
gology and Clinical Immunology (IAACI). For the next
60 years, the allergy world converged at the IAACI
triennial meetings, which became biennial in 2003.
The international meetings, originally named the Inter-
national Congress of Allergology and Clinical Immu-
nology (ICACI), are now the World Allergy Congress
(WAC) hosted by the World Allergy Organization
(WAO). Everyone who has aspired to have worldwide
recognition has played a part in IAACI-WAO. The His-
tory of the World Allergy Organization traces the
global arc of the allergy ﬁeld over the past 60 years.
The current ofﬁcers of WAO elected to focus on this
rich history, inviting prominent leaders who are inter-
ested in being part of this history project to write about
their time with IAACI-WAO. This series will be pre-
sented in Cancún, México as part of the XXII World
Allergy Congress (December 4-8, 2011). Leading up to
the Congress in Cancún, the World Allergy Organiza-
tion Journal is presenting segments of the History as
part of the “Notes of Allergy Watchers Series.” Please
enjoy.
dMichael A. Kaliner, MD
Historian and Past President (2006–2007)
World Allergy Organization
OVERVIEW
I joined the World Allergy Organization (WAO) as
a member of the Board of Directors in 1988. During the time
frame of 1988 to 2011, I have been at various times an
At-Large Member, Vice President, Treasurer (twice), Presi-
dent Elect, President, and Historian. I was never Secretary
General. I have also been in the “doghouse” at least once, and
I thought my career with WAO (at that time the International
Association of Allergy and Clinical Immunology, IAACI)
was over after 1997 (more about this episode later). This
23-year span is the second longest term of ofﬁce of any
member of the Board of Directors of IAACI/WAO, other than
Alain deWeck, who served from 1970 to 2000, a span of
30-plus years. During that period, along with my own, I have
served under the presidencies of Alain deWeck, Jacques
Charpin, Terumasa Miyamoto, Albert Oehling, S. Gunnar
Johansson, Allen Kaplan, Carlos Baena-Cagnani, G. Walter
Canonica, and Richard Lockey. I have had the fortune of
attending the congresses in Jerusalem, London, Washington,
DC, Montreux, Kyoto, Stockholm, Cancun, Sydney, Vancou-
ver, Munich, Bangkok, and Buenos Aires. This compilation
of the history of WAO/IAACI will be written from my mem-
ories, assisted by whatever archives I have been able to ﬁnd.
Following the lead of Alain deWeck, this will be a personal
history, and I will add the human elements to the histories
and recall stories as best I can and when they seem appropri-
ate. I hope the human aspects of this history are enjoyable to
the reader.
My ﬁrst exposure to IAACI was in 1979 when I had
the opportunity to give a lecture in Jerusalem for Israel Glazer
at the Congress held in Israel. I had a very positive impres-
sion of the science at the meeting, loved visiting Israel, and
decided to try to attend these meetings whenever possible. In
fact, I have had the chance to be at every congress since 1979.
I had planned to present at the 1976 congress in Buenos Aires
but was not allowed to attend by my employer because of
internal conﬂicts going on in Argentina at that time. I have
seen enormous progress in every aspect of these triennial and
now biannual meetings over the past 30-plus years.
Around 1984, I received a letter from Alain deWeck of
Bern, Switzerland, asking if he could spend 6 months in my
laboratory at the National Institutes of Health. I knew of Alain
deWeck and was well aware of his notable stature in Europe.
Not only was deWeck famous for his science but also he
was widely acknowledged as the leading immunopolitician
in Europe. He had led the IAACI, International Union of
Immunologic Societies, and World Health Organization
(WHO) and had started the Collegium Internationale Aller-
gologicum, while greatly assisting in bringing the European
Academy of Allergy Asthma and Clinical Immunology
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(EAACI) toward its current leadership position. I accepted his
offer and arranged space for him for a 6-month stay. He
arrived bringing his laboratory assistant with him, and we
embarked on a worthwhile set of experiments relating to some
complement activity.
However, as it turned out, Alain deWeck’s ulterior pur-
pose in visiting Washington, DC, was to develop the Interna-
tional Congress of Allergy and Clinical immunology (ICACI)
as the triennial meeting sponsored by IAACI, which has
planned for Washington, DC, in 1985. Both the American
College of Allergy Asthma and Immunology (ACAAI) with
Gil Barkin as President and the American Academy of Allergy
Asthma and Immunology (AAAAI) with Leonard Bernstein as
President were invited by IAACI to help organize the congress.
This meeting was held on American soil in cooperation with
the 2 allergy societies in the United States. However, the func-
tional direction of the meeting was controlled by Alain deW-
eck with the assistance of Robert Goldstein, who was Chief of
the National Institute of Allergy and Infectious Diseases extra-
mural program, responsible for administrating research grants
and other extramural activities and who functionally acted as
a Co-Chair of the meeting. Allen Kaplan, who had recently left
the National Institutes of Health for Stoneybrook, was the
scientiﬁc advisor, and I was asked to provide general support
while speciﬁcally running the social program.
For those of us taking care of allergy patients in the mid
1980s, this was a magical time. Inhaled corticosteroids were
proving to be extraordinary for rhinitis and asthma. We had
inhaled cromoglycate for asthma, a novel medication that had
focused attention on the role of the mast cell and allergy in the
pathogenesis of asthma. And, the ﬁrst nonsedating antihist-
amines were just appearing. As the Social Program Chairman
of the 1985 meeting, I was able to raise funds and hold
spectacular events, such as the All-Congress event held at the
Smithsonian’s American History Museum, which we rented
for an evening. It was a splendid setting. We had the Presi-
dent’s Reception in the Corcoran Museum. The entire con-
gress went to the Kennedy Center for a performance. But the
highlight of the meeting was the barbeque on the National
Mall. Marion-Merrell-Dow, now Sanoﬁ-Aventis, wanted to
bring Seldane, the ﬁrst nonsedating H1 antihistamine, out at
the meeting, and they wanted a big splash. Well, we had one.
We rented the space on the National Mall just north of the
Air and Space Museum, a spot now housing the National
Museum of the American Indian, and rented the largest tent
you can imagine. Unfortunately, it rained all week, and so
you could actually splash at the event! This event is the single
most memorable dinner I have attended at any meeting any-
where (and after 40 years, that includes a whole heck of a lot
of meetings). The 2500 attendees were wined, dined, square-
danced, and thrilled. Seldane went on to sell $billions before
being replaced by Allegra.
Shortly after this meeting, Alain deWeck invited me in
1985 to participate as a special Presidential Advisor to IAACI
in a very select committee, the IAACI Presidential Advisory
Committee (which included K Frank Austen, Jack Pepys,
Johannes Ring, AB Kay, and Andre Capron among others),
and in 1988, to join the Board of Directors, where I have
enjoyed the company of the leaders of allergy for the more
than 2 decades. I hope that I can point out sufﬁcient achieve-
ments to warrant such a long stay on the Board.
My memories of IAACI from 1988 through the 1990s
were that the focus was nearly solely on the triennial meeting,
which was really the primary purpose for the organization and
its major source of income. As a federation of allergy and
immunology societies, charging more than a modicum for
dues was not feasible, so income from the triennial congresses
determined what might be accomplished over the subsequent
3 years. Board meetings were generally only held annually,
and scant communications occurred between meetings. There
were no conference calls of the Board, so that the only
communication occurred by mail, very little by e-mail, and
mostly by face-to-face communication once a year.
The energy and commitment of the President were the
major determinants of IAACI’s success. He was not only
President but also the Chair of the triennial congress and
ran the scientiﬁc program committee as well. The congresses
could be fairly small, as few as 750, or large, as many as 2000
attendees. Meeting sites were selected 6 years earlier at the
triennial meeting of the House of Delegates, which is a meet-
ing where representatives from all the member societies meet
and vote on some issues of worldwide interest, such as the
meeting venue. Voting in the House of Delegates was pro-
portional to the size of membership of the society, although
the smallest society (at least 30 members) had at least 1 vote,
while the larger societies like the Japanese Society had
3 votes.
Many aspects of the Board itself were mysteries. It was
never clear how one was selected to move from an at-large
member into an ofﬁcer position or how an ofﬁcer was then
selected to become the president. At-large membership
selection for the Board of Directors was also a bit of a
mystery. The past president nominated new members largely
in consultation with a nominating committee composed of
well-known allergists who had never served on the IAACI
Board. Newly appointed members could be recycled from
retiring current Board members, who might thereby spend
extended periods on the Board while never becoming the
president. The concept of limiting the time as a member of the
Board was not considered at that time. During my early years,
the core of the Board was always European, with some
Eastern representation (always at least 1 person from Japan
and often Australia); there was always at least 1 person from
Latin America and 1 to 2 from America. The United States
presented a conundrum. It was traditional to have a represen-
tative of both the ACAAI and AAAAI on the Board, but in
the mid-1990s, in a rather xenophobic moment, the ACAAI
decided to withdraw from the IAACI, changing their minds
a few years later and reapplying for membership back into the
IAACI. During that period of disengagement, no ACAAI
representatives were appointed to the Board, so the AAAAI
was the sole source of nominees from America.
I have distinct memories of slow Board meetings, not
much ongoing activity, and what I perceived of as not much
future for this society, unless there was a sea change. Allen
Kaplan in his memoirs for the WAO history project described
this period of IAACI as an “Old Boy’s Club,” and I agree
with that characterization. Giving credit to where it belongs,
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Alain deWeck recognized the dilemma and held a retreat at
the Meadowood Resort in Napa Valley after the AAAAI
Annual Meeting in San Francisco in 1997, to discuss the
future of IAACI. After that meeting, in large part in response
to the renomination of several retiring members of the “Old
Boy’s Club” back onto the Board for recycling, a controversial
letter written by myself was sent to the Board calling for
sweeping changes. For several months after that meeting
and the subsequent provocative letter, there were heated, pas-
sionate debates over the need to modernize and democratize;
and in fact, several Board members eventually resigned and
a new, younger Board was brought into place. The slate of
ofﬁcers of IAACI was shufﬂed a bit, and I recall some hard
feelings around the Board table. At that moment, I became
a persona non grata and was demoted to Second Vice Pres-
ident, entering the proverbial doghouse.
Albert Oehling was President at the time and Gunnar
Johansson was President Elect. Gunnar Johansson understood
the issues, as did Rick Iber of Executive Director Incorpo-
rated (EDI) (the WAO Secretariat housed in Milwaukee).
Rick and I had worked on the post-Meadowood provocative
letter together, recognizing that it was certain to cause an
upheaval. When Gunnar Johansson became President, he
called for a retreat to be held at a seaside venue in Sweden in
1998. Rick Iber’s partner in EDI was Kay Whalen, now the
President of EDI, which is still the WAO Secretariat, and one
of the true assets of WAO. With the help of Rick and Kay,
a facilitator was hired who presided over the meeting, leading
to progressive discussions and a revolutionary, unifying and
exhilarating new direction for the old IAACI. Attending this
session were the members of the Board, which had become
decidedly younger after the 1997 upheaval. In a brilliant 2-
day session, we decided to focus IAACI as a global federation
of allergy societies, changing our name to the World Allergy
Organization (WAO). It was universally felt that WAO
should be much more than the host of a triennial meeting,
and objectives for education, research, and training were
identiﬁed.
The frequency of the Congress meeting was moved
from triennial to biennial and eventually was renamed the
World Allergy Congress; the tenure of the ofﬁcers were
adjusted to a 2-year duration; the goals of WAO beyond
having a scientiﬁc meeting were established; and the cur-
rent structure of WAO was initiated. The bylaws were labo-
riously redesigned (a continual activity) under the guidance
of Richard Lockey and have continued to evolve thereafter.
The length of time one can serve as a member of the Board
was deﬁned, leading to the opportunity for more countries
to be represented on the Board. WAO has emerged as a
democratic organization, with representatives chosen in equal
distribution from a worldwide pool, with consideration for
the need to represent small and large allergy societies. The
method for electing ofﬁcers and their progress through the
various elected positions was deﬁned, and democratic trans-
parent elections both to become a member of the Board and
to become an ofﬁcer became the mode. Rotation of the bian-
nual meeting around the globe assured the opportunity for
all interested societies to host this important meeting. Recent
meetings have taken place in Australia, Canada, Mexico,
Sweden, Thailand, Germany, and Argentina. We soon shall
return to Mexico, go to Italy and Korea, and perhaps the
United States.
In the period when an urgent need to revitalize IAACI
into a power for the world of allergy was recognized, from
Meadowood 1997 through the ensuing 13 years, WAO has
come into being and is now ﬁrmly established as the
worldwide voice of allergy. Not only have the 35,000 plus
allergists beneﬁted but also the hundreds of millions of
allergy sufferers have beneﬁted even more. WAO does so
much more than host a scientiﬁc congress. The needs of the
allergy sufferer and the means to provide care for these
patients is the paramount driving force of WAO, and the
organization has grown into itself in such a manner that this
former “Old Boy’s Club” is now a modern, forceful, powerful
advocate of impressive power and focus.
What a change, what an improvement, what an
achievement!
1988–1997: THE END OF THE “OLD
BOY’S CLUB”
After the extraordinarily successful (scientiﬁcally and
socially) meeting in Washington, DC, in 1985, the con-
gress moved back to Europe and was held in Montreux,
Switzerland. Jacques Charpin was the President of IAACI
when I joined the Board in 1988. However, Jacques Charpin
was ill, and Alain deWeck ran the triennial Congress, and he
did so in a unique and personal fashion. He enlisted students
from the university to assist him, so we had many charming
young people running around the congress halls, doing every-
thing that one would hire a professional organizing company
to do these days. In this manner, Alain deWeck saved money
and kept the meeting quite personal. The science of the
meeting was excellent, as it always is, and the social program
memorable, especially the dinners organized in nearby
Swiss castles. About 3500 attended the meeting and nearly
$200,000 in proﬁt was achieved.
During this period, the Board focused on the upcoming
meetings and had little interest in outside activities. Other
than the congress in Montreux, the major outside achieve-
ments were the publication of Allergy and Clinical Immunol-
ogy News, edited by Alain deWeck. Jacques Charpin became
progressively more ill during his tenure and had to resign in
1990. Albert Oehling was named acting president in 1990.
Terumasa Miyamoto became the president of IAACI
in 1991 after having organized the congress in Kyoto the
same year. The congress in Kyoto was a sound success both
scientiﬁcally and ﬁnancially. It was during this period that
IAACI, for the ﬁrst time, became involved in sponsoring
educational meetings in conjunction with member societies,
in addition to the triennial Congress. Taking advantage of
some excess income, IAACI elected to create a Seminars and
Conferences Program, which I initiated and Chaired, utilizing
$40,000 per year to organize and host up to 2 conferences per
year at WAO Member Society meetings. This initiative was
the ﬁrst time that IAACI assisted its member societies in
enhancing their educational programs and is the forerunner
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of the GLORIA (Global Resources in Allergy) and Seminars
and Conferences programs that followed later in the decade.
At the same time, under the driving force of Alain deWeck
and Jacques Charpin, IAACI published an international mem-
bership directory that allowed allergists worldwide to locate
other allergists for purposes such as referring patients who
were changing locations. This monumental work helped
place IAACI in the center of the allergy world and was
extremely useful.
During this Board of Directors meeting in 1991, the
principle that WAO would take 12% of all registration fees
from the triennial Congress was established and has been kept
in place for essentially all congresses since then, until the
World Allergy Congress in Buenos Aires in 2009.
The congress in Kyoto was attended by 2500 delegates
from 52 countries. My clearest memory, other than the sushi,
was the park just near the conference hotel. Each morning I
would join literally hundreds of absolutely quiet Japanese
people on a walk/jog around a beautiful garden and lake. Even
though the weather was wet, the number of Japanese exercising
was always huge, and the quiet, despite the numbers of people
walking/running together, was eerie. No boom boxes, no
yelling, no rowdy children, just beauty and peacefulness.
After a time of preparation, the WAO Conferences
Committee sponsored a meeting in Argentina, which although
considered quite successful educationally, was very costly.
We recognized that sponsoring conferences, in addition to the
triennial meeting, required ironclad constraints. The major
contribution of this program to the development of IAACI
was that it opened up the opportunity for member societies to
be directly supported by IAACI, and it gave IAACI a presence
other than the triennial meeting. I recall that all communica-
tions took place by mail and that it literally took months for
any consensus to be achieved. Thus, the pace of activities in
1988 to 1994 seems so slow by today’s perspective, but it was
unavoidable based upon the communications systems in place
at the time.
In 1993, recognizing the need to move outside of the
restricted objectives of the old IAACI, Alain deWeck and Rick
Iber developed the Perspectives in Allergy Program (POA),
sponsored by Marion-Merrell Dow. This program was designed
to place seminars focused on allergy or clinical immunology
at nonallergy meetings as a way to teach nonallergists some
of the principles of allergy. In addition, symposia were also
held within major European allergy meetings. As a European
program, the advisory committee was entirely European. An
ambitious program of seminars was created and the time had
come for IAACI to move outside of itself.
Thus, in this short period, 2 programs were developed
by the IAACI that increased its worldwide presence and
have been the starting point for future developments. While
Terumasa Miyamoto was then the President and he fully
supported these programs, Alain deWeck was the consistent
driving force behind them and Rick Iber of the Secretariat
provided much of the creativity and funding prowess. The
POA program got off to an impressive start, with meetings in
Florence, Jerusalem, Stockholm, Berlin, and Austria.
The 1994 congress in Stockholm was an important
turning point for IAACI. The meeting was conducted in
conjunction with EAACI, had a very large attendance (4700
paid participants plus 1400 others), and led to the eventual
presidency of Gunnar Johansson (1997–2000), who rightfully
deserves much credit for the revitalization of IAACI and the
creation of WAO (Fig. 1). The congress in Stockholm was
a success in every respect, including a $300,000 proﬁt. As a
result, IAACI became much more widely recognized as
a global power in allergy.
The congress in Stockholm was held during glorious
spring weather, in a near-perfect setting, by a welcoming host.
WAO and EAACI advertised the meeting extensively and I
was certain that hundreds of Americans would attend the
meeting. After all, it was held in June in an inviting country
and surely Americans would ﬂock to Sweden when the
chance was provided. In my certainty, I assured Gunnar
Johansson that 600 Americans would attend his congress.
To my disappointment, registration from the United States
was small (about 200), and Gunnar Johansson always asks
me about the missing 400 Americans. I still do not know
where they are! Had they attended, they would have enjoyed
the wonderful science, the splendid countryside, a wonderful
All-Congress event at the city park, Skoda, and the hospitality
of one of the warmest countries in Europe. Too bad!
After the congress, about 50 of us traveled to Helsinki
and St Petersburg for a week, where we experienced con-
tinuing medical education lectures presented on the bus
returning to the hotel, the absence of Allen Kaplan who got
misplaced outside the Hermitage, the rescue of Marcia Fireman
(Phil Fireman’s wife) from some marauding gypsies, and the
reality of an authentic Soviet hotel, where the towels were
more than 20 years old and truly threadbare. Despite their
age, these towels were valuable to the hotel, and when my
family tried to check out, a towel missing from my children’s
FIGURE 1. SGO Johansson, WAO President (1997–2000).
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room meant that we could not leave. Amazingly, this relic was
discovered in time for us to check out, but I still wonder what
might have happened if the towel had not turned up.
WAO is a federation of national and regional allergy,
asthma, and immunology societies. It is the allergy societies that
belong to the organization, not the individuals. Dues are paid by
the societies and are derived from whatever sources of income
the societies have in place. The dues to belong to IAACI/WAO
had been ﬁxed since 1951 at 2 Swiss francs per member. In
1994, there were about 25,000 allergists worldwide, and thus the
dues yielded about $40,000 per year. The budget for expenses
during the year the congress takes place was in the order of
$3,000,000. This imbalance between budget and income was
dangerously out of balance, as any untoward event could lead
to bankruptcy. After a long and arduous debate, ﬁrst in the Board
of Directors and then at the House of Delegates, it was agreed to
increase the dues to 5 Swiss francs per member. Anyone reading
this document will recognize that this is still a paltry amount, but
the painful discussion leading to this increase in dues remains
vividly in my memory, as it underlines some of the major per-
plexing issues any international society faces as it grows.
Albert Oehling became president in 1994 for the second
timedhe had presided as acting president at the end of
Jacques Charpin’s term, when he became ill and had to resign
(Fig. 2). During his term, the Seminars and Conferences Com-
mittee hosted meetings in South Africa, Hong Kong (leading
to the creation of the Hong Kong Allergy Society), and
Poland. At this time, pharmaceutical companies were begin-
ning to recognize how partnering with IAACI could be helpful
in educating physicians about allergies and their treatment,
and the incredible value IAACI offered. Astra Pharma-
ceuticals became our second partner committing to a 3-year
program, “Global Aspects of Allergy and Immunology.”
Unfortunately, this program only lasted 1 year before Astra
withdrew support, as the company initiated a very restrictive
policy on asthma education, which still exists to this day.
In 1996, the ACAAI withdrew their membership from
IAACI. This abrupt withdrawal occurred at the same time
that the number of new societies trying to join IAACI was
blossoming, so withdrawal by a major society was rather
shocking to everyone. The ACAAI representative to the
Board at that time was Bud Bardana from Oregon, and he
was not aware that ACAAI had intended to withdraw, nor
could he explain the reasons. The stated reason was that the
increased dues of 3 Swiss francs per member would cost more
that the perceived beneﬁts received by the society. At that
time, there were 34 member societies, and about 10 additional
societies were considering joining IAACI. The total cost of
dues worldwide in 1995 was $76,000 and the share that
ACAAI had been expected to pay was about $8,000; the
AAAAI was paying $18,000 at the same time.
In 1997, ACAAI reversed their decision and reapplied
for IAACI membership. In that same year, 13 societies
applied to become new members, underlining the growing
importance of IAACI in the world of allergy. Nonetheless, the
damage to the ACAAI had been done and in this period, only
the AAAAI was represented on the IAACI Board.
As for IAACI’s outside activities, a new program was
initiated sponsored by Rhone Poulenc Rorer entitled the World
Allergy Forum (WAF) (Fig. 3). The purpose of this program
was to present “state of the art forums” at allergy meetings.
Between the years of 1997 and 1998, 8 programs were devel-
oped. The WAF has continued since 1994, the funding has
changed from Rhone Poulenc Rorer to Novartis, and it is still
called the World Allergy Forum. The WAF has sponsored
sessions at both the AAAAI and EAACI continuously for 17
years and is the longest running educational program of IAACI/
WAO. On years where there has been sufﬁcient funding, WAF
has added programs at the ACAAI and other venues as well.
FIGURE 2. Albert K. Oehling, WAO President (1994–1997). FIGURE 3. Logo of the World Allergy Forum.
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The POA program lost funding brieﬂy in 1996 but was
renewed by Hoechst Marion Roussel (now Sanoﬁ-Aventis)
for 1997–1998, and several programs were presented. The
Seminars and Conferences committee elected not to develop
any programs in 1997 but resumed operations in 1998.
Following the Executive Committee meeting held in
conjunction with the AAAAI meeting in San Francisco in
February 1997, a retreat was held at Meadowood in Napa
Valley, CA. This retreat led to a paper referred to by Alain
deWeck as the Meadowood Manifesto, which was directed at
the future of allergy.
Shortly thereafter, another “manifesto”was created by me,
with the silent support of Rick Iber, addressing the need of
IAACI to change its image and direction and to enlist younger,
more vital, more energetic leaders interested in expanding the
IAACI to its potential. This letter was sent to WAO President
Albert Oehling but was also copied to the Board. I recall a huge
uproar after this note was received and digested. There were
a ﬂurry of notes, some condemnations, and a few approvals.
However, several established Board members elected not to
continue past 1997, and the opportunity to revitalize the Board
ensued. The period between March 1997 and the congress in
Cancun later that year was full of behind-the-scenes discussions
and decisions. I recall one well-respected Board member stating
that he preferred to have older, more mature Board members
because they had already fulﬁlled their ambitions. While this
position has merit, the need to make IAACI more democratic,
with a broader world representation and a more involved and
vital leadership outweighed this argument. I believe that the
1997 letter actually precipitated the events that occurred in
1998 that have revitalized WAO. Rereading it 15 years later, I
recognize that the impudence and emotion that led to that letter
were well-meaning and effective, but this was an incredible
bomb to lob into the laps of a staid and reserved group of
otherwise well-meaning allergy leaders. I think is likely that
all is well that ends well. But, I wonder how I would have
reacted had I been the current president.
The triennial meeting in 1997 was held in Cancun,
Mexico. For the ﬁrst time, there was quite substantial
pharmaceutical sponsorship, representing an income of about
$1,600,000. The scientiﬁc program was developed nearly
exclusively by the President and Chairman of the meeting,
Albert Oehling. Despite asking for very limited input from his
Scientiﬁc Program Committee, he created a creditable scien-
tiﬁc program. The organization of the meeting was run inter-
nally by EDI, and they did an excellent job. The social aspects
of the meeting were delightful, and Cancun was a huge suc-
cess. More than 6500 attended the meeting and a huge proﬁt
of $600,000 was realizeddthis represents the single largest
proﬁt made by IAACI from any meeting to that time.
1998–2000: THE END OF IAACIdTHE START
OF WAO
On the heels of a very successful meeting in Cancun,
and with more money in the bank than ever before, the
leaders of IAACI could look internally and decide if the time
was ripe for change. Remember that we had just completed an
extremely challenging period, when the “Old Boy’s Club”
had been challenged publically by a prominent executive
committee member, and there had been resignations and
internal changes that followed shortly thereafter. With Gunnar
Johansson as an imaginative and courageous president, the
time for serious consideration of the future of IAACI came
into sharp focus. During a 2-day period in late August 1998,
the following leaders met and changed the future of IAACI
into the World Allergy Organization: Gunnar Johansson,
Michael Kaliner, Carlos Baena-Cagnani, Allen Kaplan,
Albert Oehling, Johannes Ring, Robert Davies, Francois-
Bernard Michel, Mitsuro Adachi, G. Walter Canonica, Con-
nie Katelaris, Richard Lockey, Joao de Mello, Joaquin Sastre,
and Daniel Vervloet, along with Rick Iber and Karen Henley
from the Secretariat.
The end result of this retreat was to change the entire
focus of the organization and to take the name World Allergy
Organization. As you might imagine, there was a huge dis-
cussion about discarding the old IAACI name and also not
claiming clinical immunology in the title. If you review the
history of IAACI written by Alain deWeck as part of this
project, you will see that the basic immunologists had already
removed themselves from IAACI, and clinical immunology
had become integrated into many organ-based specialties.
Thus, it was more a recognition that WAO represented allergy
as its core constituency and that clinical immunology was part
of WAO much as it is part of dermatology, rheumatology,
nephrology, transplantation, and the like. But the decision to
focus on allergy and to represent the allergist and the huge
segment of the population suffering from allergy was a giant
step forward and moved the organization toward a true global
power more than any other decision.
A plan to transition from the name IAACI to WAO over
several years was created with a gradual phasing out of the
IAACI name. The vision of WAO was to optimize allergy
care worldwide. The organization would exist to build a global
alliance of allergy and immunology societies to advance
excellence in clinical care, research, education, and training.
Five areas of focus were identiﬁed: education, communica-
tion, global recommendations, cooperation and research, and
training. Plans to institute these changes were put into place
from 1998 to 1999.
It is difﬁcult to describe the excitement of this retreat.
The setting was the Grand Hotel Saltsjobaden, the site at which
the great racing yachts of Sweden are housed. The weather was
bright, the atmosphere was exciting, and the creativity could be
felt. We all knew we were creating something of value, and
for me, years of frustration were ﬁnally coming to an end. This
was going to be something into which you could put your
heart and soul, and the beneﬁts would be immense. One very
pleasant memory from the weekend was taking a huge walk
for several hours with Richard Lockey, during which we
smoked Cuban cigars (which he provided, being from Tampa)
and planned the revision of the bylaws. Subsequently, he and I,
along with others, worked and reworked the constitution and
bylaws again and again over the next 10 years; and there are
still ambiguities, but it is a democratic transparent document
that allows a growing and increasingly more vital global
organization to grow and succeed.
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As noted throughout this report, WAO’s initiatives
and commitments to support its member societies was ever-
growing and was perceived to have the second largest impact
on the world’s perception of WAO after the triennial meeting.
To better support this outreach programming, the Seminars
and Conferences Committee restructured and began to provide
select speakers to member society meetings on an application
driven basis. With this change, between 4 and 8 speakers
were sent each year to allergy meetings throughout the world,
with each speaker solely sponsored by WAO. During 1998
to 1999, this program sponsored lectures in Australia, Great
Britain, Korea, Norway, Turkey, Argentina, Ecuador, Hungary,
and Italy (Fig. 4).
The WAF program continued to provide 2 or 3 seminars
at other allergy meetings, largely in Europe and the United
States. The seminars were held in San Francisco, Rhodes,
Cancun, Maui, Hawaii, Washington, DC, Birmingham, the
United Kingdom, Manila, and the Philippines, during 1997
and 1998. The POA program sponsored meetings in
Lisbon, Berlin, Cancun, Paris, Cordoba, and Vienna during
1997 and 1998. Thus, these outreach programs were having
a major effect on the world of allergy during this
transitional period and further raising the awareness of
IAACI/WAO.
Gunnar Johansson created a new program GLORIAd
Global Resources in Allergy (Fig. 5). This new program was
to be unique. To better arm our constituents to teach allergy
to others, GLORIA would include a lecture (for example on
allergic rhinitis) at a national allergy meeting, then the
speaker would meet with the local allergists, review the
slides, and provide them with copies of the slides that they
could use to give subsequent lectures either to allergists or
family doctors. Thus, this was a 2-tiered outreach programd
from WAO to its member societies and then from a society to
local medical doctors.
Not only was the concept of GLORIA unique, so was
the idea of sponsorship. Pharmaceutical companies were asked
to contribute a relatively small amount ($45,000 per company),
and multiple companies were enlisted to sponsor the program.
We gave equal credit to each sponsor, and then opened up
GLORIA to WAO Member Societies. The initial lectures were
allergic rhinitis and allergic conjunctivitis. Over the next
10 years, lectures were prepared and posted for downloading
on the WAO Web site (www.worldallergy.org), covering
these additional topics: Allergic emergencies, immunotherapy,
treatment of severe asthma, food allergy, angioedema, anaphy-
laxis, diagnosis of IgE sensitization, chronic rhinosinusitis and
nasal polyposis, drug allergy, and urticaria. These slides have
been downloaded by thousands of allergists and presented to
countless physicians worldwide; many have been translated
into Spanish. By any account, the GLORIA program has been
an immense success.
By 1999, the priorities of IAACI/WAO were coming
into focus: improve the triennial, now biennial, meeting,
rewrite the constitution, develop global recommendations,
develop cooperative relationships with other global organ-
izations as well as with WAO Member Societies, and help
develop a fellowship program. Each area of focus developed
short, mid, and long-range goals. The strategic statements for
each area of focus were resolved, as below.
Education: Provide state-of-the-art continuing medical
education for members and member societies through the
biennial congress and provide educational opportunities for
other medical professions outside of the allergy-related spe-
cialties to achieve optimal allergy care worldwide and direct
and support patient education and advocacy.
Communications: Improve communications with mem-
ber societies, develop communication strategies for all initia-
tives, and utilize external communication for enhanced public
relations, medical relations, and nonmember communications.
Global recommendations: Develop and endorse guide-
lines and develop strong relations with associations such as
the World Health Organization.
Cooperation: Develop partnerships with member soci-
eties, other national and international societies, industrial
sponsors, and patient groups.
Research and training: Support and promote advo-
cacy for research in allergy and immunology globally and
nationally, deﬁne and promote the roles of the specialist
and subspecialist, and support training of future allergists.
One of the most concrete reﬂections of the new
WAO initiatives was the development of the Web site,
www.worldallergy.org. It was envisioned that the Web site
could be the clearinghouse for international statements, posi-
tion papers, and global recommendations. The plan was to
have both professional and patient-oriented portions of the
Web site. Initially, the Web site was called the Global Allergy
Information Network (GAIN) and was sponsored by Aventis.
A move to develop a World Allergy Awareness Day
was begun. Originally, it was conceived to be a partnership
with the WHO, and it always was based upon a central
leadership (WAO) assisting a global outreach (the national
societies that constitute WAO). World Allergy Awareness
Day was to be a professional and patient cooperative action.
The ﬁrst event was held in Sydney, Australia, during the XVII
International Congress of Allergy Asthma and Immunology
in Sydney in October 2000. The timing was to be determined
FIGURE 4. Logo of the Seminars and Conferences program
of the World Allergy Organization.
FIGURE 5. Logo of the GLORIA – Global Resources In
Allergy – program of the World Allergy Organization.
WAO Journal  November 2011 Two Decades Leading to World Leadership
 2011 World Allergy Organization 237
by each allergy society, using the timing that worked best for
each geographical region. Working with the WHO turned out
to be problematic, and without going into detail, did not
develop. The idea of a World Allergy Day continued for the
last decade, with no generally agreed upon plan. Individually,
countries sporadically developed their own plans in associa-
tion with the WAO initiative, with some degree of local
success. In 2010, the WAO Communications Council, with
Marek Kowalski as Chair, proposed to the Board the concept
of World Allergy Week, to be held at the same time each year
and independent of any congresses (Fig. 6). I have high hopes
that the new plan will be more successful at a global level.
The congress in Sydney in 2000 had extremely bright
spots, but unrelated to the Congress itself, this was a time for
some low memories as well. The bright events included an
excellent, extremely well-organized meeting with ﬁrst-rate
science and a chance to meet many scientists from the eastern
world. Connie Katelaris and her colleagues did an amazing
job. Sydney was a wonderful city, full of interesting things
to do, and very welcoming. The social program was excellent,
and everyone left the meeting elated. This congress was highly
successful ﬁnancially with a net income of above $300,000.
The disturbing issues dealt with the Secretariat and
a sad disappointing exit by our friend and advisor Rick Iber,
who resigned from EDI and his role as Executive Director of
IAACI abruptly just before the Congress, and left IAACI in
some disarray. I recall sitting as the Treasurer at the Board’s
presentation to the House of Delegates realizing that I did not
have a ﬁnancial report that I could present. I had been Trea-
surer for 6 years and certainly knew our ﬁnancial status, but
as mentioned earlier, we were in a bit of a tough time, and I
wanted to give an accurate report, not an estimate; and those
numbers just were not available. So, for the ﬁrst time in my
professional life, I was forced to report to my peers that I
could not give a report, but that as soon as numbers became
available, we would share them with the member societies. As
it turns out, we were ﬁnancially secure, with enough revenue
from a number of our outreach programs that we were solvent
and have remained so ever since. But, I would rate this
moment in my memory as my low point professionally. This
disarray at the end of Gunnar Johansson’s term as the presi-
dent was unfortunate, but we soon recovered. Allen Kaplan
became the president in 2001, the last president to serve a
3-year term (Fig. 7).
It was at the congress in Sydney in 2000 that the House
of Delegates reviewed and approved the overall concepts
generated at the retreat held in 1998. Thus, ofﬁcially, IAACI
became WAO in 2000. Approval to radically change the
bylaws was given, and the overall concepts engendered by
the retreat were approved. The location and timing of the
congress that would follow the next one in Vancouver (2003)
was chosen to be Munich in 2005 in conjunction with EAACI
and the German Allergy Society. Because of the change in
timing to a 2-year cycle, the House of Delegates also selected
the 2007 location of Bangkok in Thailand. It was at this
congress that there was recognition of the enormous contri-
butions that Alain deWeck had made to IAACI/WAO and to
world of allergy and immunology. After a 30-year stint on the
Executive Committee of IAACI, and after having effectively
led the organization for much of this time, it was ﬁtting that he
received a universal standing recognition for his achievements.
2000–2003: SOLIDIFYING PROGRESS IN THE
NEW WAO
Allen Kaplan had been on the WAO Board since 1991,
had previously been the president of the AAAAI, and knew
how to run a large organization. The WAO Secretariat at EDI
regained its footing quickly, placing Gail Bast as the
Executive Director. As always, Kay Whalen was the quiet
power behind the scene, being ready and capable to make
certain that WAO always remained stable. Kay Whalen has
been the major hidden asset of EDI since the very beginning
of the relationship with IAACI/WAO. She has guided Don
McNeil, Rick Iber, Sally Kolf, Gail Bast, Denise Lemke, Stan
Mandarich, Karen Henley Davies, and Charu Malik with
balancing the intricacies of an international organization and
the ever-changing personalities of the ofﬁcers.
FIGURE 6. Logo of the World Allergy Week 2011 initiative of
the World Allergy Organization.
FIGURE 7. Allen Kaplan, WAO President (2000–2003).
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The XVIII International Congress on Allergy and
Clinical Immunology in 2003 was planned for Vancouver,
Canada, with Estelle Simons and Michael Kaliner assisting
Allen Kaplan; many of the outreach programs (WAF, GAIN)
were working well; and GLORIA was about to begin. It was
a time to make certain that WAO was ready to become
a world power and to be certain that we did not overreach.
Allen Kaplan’s solid imperturbable personality and an abun-
dance of careful planning were a perfect follow-up to the
dynamic but sometimes chaotic period that had proceeded.
Connie Katelaris, with the active support of Allen
Kaplan, initiated a new program with a unique concept: WAO
would foster developing allergy societies with the Emerging
Societies Program (ESP) (Fig. 8). We recognized in retrospect
that the meetings we had organized in several countries dur-
ing the mid 1990s had turned out to be instrumental in assist-
ing these countries toward developing an allergy society and
eventually joining WAO. The ESP plan was to identify coun-
tries with ﬂedgling societies and to invite them to meet with
other regional ﬂedgling societies along with leaders from
WAO to provide information and support to help them
develop into independent allergy societies. The ﬁrst ESP took
place in Seoul, South Korea, in conjunction with the annual
meeting of the Asia Paciﬁc Allergy Asthma and Clinical
Immunology (APAACI) meeting in 2002. This ESP meeting,
and essentially all subsequent meetings, was cosponsored by
WAO and ACAAI. ESP has continued from 2001 through
2011, with a string of educational programs in many devel-
oping parts of the world and has led to the emergence of
dozens of new allergy societies, which have subsequently
contributed to WAO. From the start of this program, ACAAI
has remained an active partner with WAO, providing both
educational and ﬁnancial support.
The Web site (www.worldallergy.org) was originally
called GAIN (the Global Allergy Information Network) and
was sponsored by Aventis Pharmaceuticals and subsequently
by Novartis. Novartis has remained the sponsor for most of the
decade, and without their support, the task of building a ﬁrst rate
Web site would have been more challenging. Novartis has been
advised by Keith Allen, who started with Aventis/Rhone Poulenc
Rorer and has remained the most stalwart of all the supporters of
WAO through the years. Keith initially advised Aventis to work
with WAO with educational programs and the Web site (GAIN),
and after moving to Novartis has maintained constant support
from this company both for the Web site and for WAF, the
longest running of all the WAO outreach programs.
It needs to be noted that Aventis (now Sanoﬁ-Aventis)
was an early and major sponsor of WAO, largely due to the
support of Greg Lund, who still remains today actively
advising various pharmaceutical companies and who contin-
ues to support WAO with new programming. TEVA Pharma-
ceuticals is currently sponsoring a special program on small
airways diseases, which was brought to WAO by Greg Lund
and is providing state-of-the-art lectures throughout the
world on this topic. Much of the success of WAO over the
past decade is due to imaginative outreach programs, many of
which have received pharmaceutical support, and much of
the credit for this critical sponsorship has to be given to
individuals like Greg Lund and Keith Allen.
Internally, the plan to strengthen the organization of
WAO involved creating 5 councils: education, communica-
tions, research, specialty and training, and congress organi-
zation. Each of these councils was empowered to create
initiatives that supported WAO and world allergy.
The Communications Council was initially directed by
Richard Lockey, and it took over responsibility for the Web
site and the journal (Allergy and Clinical Immunology Inter-
national), which is addressed more fully in Alain deWeck’s
comments.
Two important papers were created by WAO from 2002
to 2004. The ﬁrst was the “Prevention of Allergy and Allergic
Asthma (PAAA),” which was initially proposed to be a joint
venture with WAO and WHO but in the end was a WAO pro-
ject, which was provided to WHO. The editors of PAAA were
Gunnar Johansson and Tari Haahtela, and the chapters were
written by a cast of internationally recognized experts. This doc-
ument was published as an editorial summary in time for the
congress in Vancouver in 2003, and it was widely recognized as
an important document. The full document came out as a book
in 2004. The topic is so important that there is current consid-
eration for WAO to create a revision and update of this topic
(http://www.worldallergy.org/professional/who_paa2003.pdf).
The second document, “Revised Nomenclature for
Allergy for Global Use: Report of the Nomenclature Review
Committee of the World Allergy Organization, October 2003,”
was an initiative to clarify allergy nomenclature spearheaded by
Gunnar Johansson. This simple but straightforward document
addressed some of the strange allergy phrases that were being
used at the time, “pseudoallergic” and “anaphylactoid”, for
example, and to make a simple scientiﬁcally based set of sug-
gestions for accurate nomenclature (http://www.sciencedirect.
com/science/article/pii/S0091674904009303).
The congress in Vancouver in 2003 was chaired by
Allen Kaplan with Estelle Simons and Michael Kaliner as the
FIGURE 8. Logo of the Emerging Societies Program (ESP) of
the World Allergy Organization.
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organizers. The planning and organization of the meeting was
done transparently, with regular input from the Board and the
Scientiﬁc Program Committee. The congress was held in
September 2003 as a joint venture with the Canadian Allergy
Society and in cooperation with both the AAAAI and
ACAAI. As always, the Congress was a resounding scientiﬁc
success. For the ﬁrst time, a relatively large contingent
from the United States attended the congress, but the total
attendance was disappointing. The attendance had been pro-
jected at over 3000 but only 2250 attended, a number affected
by worldwide concerns over severe acute respiratory syn-
drome (SARS), which was endemic in parts of Canada, as
well as the newly appreciated threats of world terrorism that
had began after the destruction of the Twin Towers in New
York City on September 11, 2001. Nonetheless, the meeting
yielded a proﬁt of over $800,000 (the largest proﬁt ever gen-
erated by WAO) and was considered a solid scientiﬁc success.
The social programs were interesting and well attended, and
Vancouver turned out to be a good host city for international
events. The issues of SARS and 9/11 underscore the difﬁcul-
ties in relying on international meetings for essential income.
Overall, Allen Kaplan’s tenure as WAO President
solidiﬁed the gains achieved over the preceding transitional
years and led to a solid beginning for WAO, as it emerged
from the IAACI beginnings. During 2000 to 2003, our Exec-
utive Director was Denise Lemke. Carlos Baena-Cagnani
became the president of WAO in September 2003 after the
congress in Vancouver and served until November 2005. The
Executive Director from EDI during this time was Stan
Mandarich. The World Allergy Congress was now an every
other year event, and it was to be held in June 2005 in Munich
in partnership with the German Society for Allergology
and Clinical Immunology and EAACI. Johannes Ring was
the Co-Chair (representing Germany) along with Carlos
Baena-Cagnani and Anthony Frew (from EAACI).
Carlos Baena-Cagnani started his presidency with
several clear-stated goals (Fig. 9). He wanted to explore
individual memberships for allergists in WAO, start a junior
member’s group, and enhance WAO’s relationship with the
WHO. The question of individual members of WAO had been
explored from the onset of IAACI more than 50 years earlier.
The charter of WAO precludes individual members to prevent
WAO from competing with its member societies for both
members and dues. Thus, after discussions and a careful
review of this topic, it was agreed that membership in
WAO is for societies only. The junior member idea has been
discussed for a decade, and only now, with the launch of the
WAO Junior Members Group in March 2011, has the concept
become a reality (www.worldallergy.org/juniormembers). The
concept is now to offer incentives to young allergists to par-
ticipate in WAO as a way to start a lifelong habit of keeping
WAO on the agenda, not to make them individual members.
During this time frame, Richard Lockey started a
bi-monthly electronic newsletter, WAO News and Notes, to
be sent to all WAO members for whom we had an e-mail
address. Richard Lockey’s concept was to have WAO News
and Notes simultaneously translated into several languages to
make it more accessible to the readership. Use of the e-mail
method allowed WAO to communicate with 35,000 allergists
worldwide, saved considerable money, and allowed for
instantaneous communication. The WAO News and Notes
newsletters were an immediate success. In fact, this commu-
nication was so successful that it went from every other
month to monthly, and we now have an e-mail communica-
tion every 2 weeks, with the WAO Reviews (of the current
literature) newsletter alternating with the WAO News and
Notesmailings. Richard Lockey enlisted the support of a com-
mitted group of editors who have donated their time to trans-
late the electronic newsletters into 8 or more languages. The
success of theWAO News and Notes subsequently had a major
effect on WAO’s journal, leading the organization to launch
an electronic journal in 2008 (much more about the journal
and its trials and tribulations later).
In 1992, there were 35 member societies within WAO.
By 2004, there were 70 members, including afﬁliate and other
nonvoting members. This increase in membership reﬂects the
rapid growth of WAO during the decade from 2000 to 2010.
At the end of the decade, there were 85 member societies.
Around this time, led by Carlos Baena-Cagnani and Walter
Canonica, WAO began to host meetings with member
societies at major international meetings, such as EAACI
and AAAAI. These 2-hour sessionsd“Member Society
Forums”dwere immediately successful, gave an opportunity
to enhance communications with WAO Member Societies and
gave the societies a new mechanism for feedback. These
Member Society Forums have continued from 1994 to the pre-
sent and have proven to be a valuable communications tool.
One area where WAO had always had an interest but
for which little had been done was sponsorship of research
fellowships. During 2004 to 2006, in part based upon
sufﬁcient funds being in the bank as an offshoot of the
FIGURE 9. Carlos E. Baena-Cagnani, WAO President (2003–
2005).
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ﬁnancially successful congress in Vancouver in 2003, a trial
of WAO funded research fellowships was tried. Two offer-
ings were developed: A limited 2- to 6-week rotation to
a research laboratory to learn a new technique and a 2-year
fellowship as a research fellow by a young applicant to an
established laboratory. Both of these initiatives were success-
ful, but it was clear that at this point, WAO was probably not
the right body to administer and supervise research funding.
Both of these funding ideas have merit and are needed by the
community, but there was no continuity of funding, the Board
turned over too quickly, and the WAO Secretariat required
a lot of time to supervise recipients and sponsors. Thus, while
in the best of worlds, WAO would like to offer research
funding, in the real world, our experience was that other
organizations can do this sort of initiative far better than
WAO. This may, however, change with the new initiative to
develop WAO Collaborative Centers of Excellence, which is
in planning in 2011.
In 2005, in conjunction with the congress in Munich,
WAO renamed the biannual meeting, the World Allergy
Congress (WAC). The Congress had been known for decades
as the International Congress of Allergology and Clinical
Immunology (ICACI), the World Allergy Organization Con-
gress, and now WACdthis is the name that will remain from
now on, as it is simple and states exactly what the congress is.
The outreach programs of GLORIA, GAIN, and WAF
continued growing and improving throughout this period.
GLORIA was the most vulnerable program, as it required
multiple sponsors for its continuation. There were 8 original
cosponsors of GLORIA in 2001, but by 2005, there were
just 3. The problems were that sponsors wanted a program
they could say was their own and to support lectures that
directly related to a product-related interest on their commer-
cial side. Despite trying to make GLORIA more attractive to
sponsors, the pharmaceutical support dwindled. To instill new
life in the program, we created a new initiative, an American
version of GLORIA. This project was cosponsored by the
ACAAI, who provided the Continuing Medical Education
(CME). The “US GLORIA” was immediately successful, and
6–10 programs per year were sponsored at regional, state, and
local allergy societies between 1995 and 2010.
Unfortunately, the whole world of pharmaceutical
support changed in the time frame of 2008 to 2010. Markedly
increased overview was imposed on the pharmaceutical
industry by programs of the US Food and Drug Administra-
tion (FDA) that were created to be restrictive rather than
supportive. Congressional interest in medical education led by
Iowa’s Senator Grassely focused on apparent excessive “give-
aways,” but overlooked the important education provided by
the industry to physicians. The inﬂuence of these oversight
initiatives generated extreme caution by the pharmaceutical
companies and led to a signiﬁcant and rapid reduction in
educational funding. Programs such as GLORIA and many
pharmaceutical-sponsored education programs at national
meetings, including the WAC, were curtailed. This reduction
in sponsoring medical education is the classic example of
cutting off one’s nose to spite the face. Everyone has suffered.
There is far less education available to the physician, and no
funds are available for patient education. Physicians can no
longer attend sponsored CME meetings where a general topic
can be addressed (such as asthma or anaphylaxis), as the
industry will now only sponsor promotional talks, which
require the use of internally approved slides and a restricted
discussion of an FDA-approved product kept within the pack-
age insert. I believe that within a few years, pharmaceutical
companies will once again realize that education of physicians
about best practices is by far the most efﬁcient way to intro-
duce a product into a prescribing physician’s treatment plans.
I wonder if the FDA and its European counterpart will have
the insight to create room for educational programs that are
more useful than the current promotional talks. I have no
hope that Senator Grassley will ever see how his pressure
on the US Congress and FDA has hurt the very industry he
has tried to support, but senators come and go, so his time will
end eventually.
Getting back to GLORIA, this excellent program has
educated tens of thousands of physicians about the best prac-
tices of allergy, and it is still running in a more limited fashion
with the hope that funding might again increase once the
pharmaceutical industry realizes this program’s immense value.
By mid 1995, the Specialty and Training Council had
completed a survey of the adequacy of the provision of allergy
services worldwide and had conﬁrmed that the number of
allergy-trained physicians was woefully short of the number
needed. This survey was published in Allergy and Clinical
Immunology International. However, the Specialty and Train-
ing Council, led by John Warner, Sergio Del Giacco, and
myself, recognized that many countries were shifting allergy
care to nonallergy specialists who had an overlapping interest
in allergy but who were not sufﬁciently trained in allergy
(such as dermatology, ear, nose, and throat [ENT], gastroen-
terology) or to primary care physicians who often or mostly
had received no specialized training in allergy. This council
took several actions of critical long-term consequence. Start-
ing in 1995 and continuing through to the current council, this
group has created several WAO position papers designed to
deﬁne the specialty, the training required to adequately care
for patients with allergic and immunologic disease, and the
need for to train adequate numbers of allergists to provide care
for the hundreds of millions of allergy sufferers.
These papers include the following:
1. Del Giacco S, Rosenwasser LJ, Crisci CD, et al. What is
an allergist? A Position Statement of the WAO Spe-
cialty and Training Council. World Allergy Organ J.
2008;1:19–20.
2. Kaliner MA, Del Giacco S, Crisci CD, et al; on behalf of
the WAO Specialty and Training Council. Require-
ments for physician competencies in allergy: key clini-
cal competencies appropriate for the care of patients
with allergic or immunologic diseases: a position state-
ment of the World Allergy Organization. World Allergy
Organ J. 2008;1:42–46.
3. Potter PC, Warner JO, Pawankar RS, et al; for the WAO
Specialty and Training Council. Recommendations for
competency in allergy training for undergraduates qualify-
ing as medical practitioners: a World Allergy Organization
Position Paper. World Allergy Organ J. 2009;2:150–189.
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4. Warner JO, Kaliner MA, Crisci CD, et al. Allergy prac-
tice worldwide: a report by the World Allergy Organi-
zation Specialty and Training Council. Allergy Clin
Immunol Int. 2006;18:4–10 and International Arch
Allergy Immunol. 2006;139:166–174.
All of these papers are accessible at www.worldallergy.org.
The development of these position papers opened up
a new way for WAO to inﬂuence the world of allergy. A system
designed to promote the development of global position papers
to the world of allergy was developed. Papers considered
warranting designation as a position paper of WAO were initially
developed and written by a committee selected by WAO and
after internal review were published provisionally. Each WAO
Member Society in the world was subsequently invited to
comment upon and add suggestions to the text. The suggestions
were reviewed and the text reconciled. Finally, each society was
asked to approve the paper, which was initially published in the
World Allergy Organization Journal. Each allergy society was
ﬁnally requested to republish these important statements in their
own society journals in their native languages. Thus, the plan
was for WAO to act as the global initiator and clearinghouse of
position statements that are created to address global problems
and to have the weight of the entire world body of allergy behind
them. This process is still evolving. In 2011, WAO, EAACI and
AAAAI agreed to work together to summarize existing global
guidelines and are discussing ways to create global statements of
importance in concert by these 3 organizations.
Over the past 5 years, WAO has published an impressive
series of position papers, each of great importance to the
specialty and ranging from immunotherapy to milk allergy to
anaphylaxis. These publications are accessible via the WAO
Web site, www.worldallergy.org, under WAO publications
(http://www.worldallergy.org/publications/).
1. Simons FER, Ardusso LRF, Bilò MB, et al. World
Allergy Organization guidelines for the assessment
and management of anaphylaxis. World Allergy Organ
J. 2010;4:13–37; February 2011.
2. Fiocchi A, Brozek J, Schünemann H, et al. World
Allergy Organization (WAO) Diagnosis and Rationale
for Action against Cow’s Milk Allergy (DRACMA)
guidelines. World Allergy Organ J. 2010;3:57–161.
3. Fiocchi A, Brozek J, Schünemann H, et al. World Al-
lergy Organization (WAO) Diagnosis and Rationale for
Action against Cow’s Milk Allergy (DRACMA) guide-
lines. Pediatr Allergy Immunol.2010;21(suppl 21):
1–125.
4. Canonica GW, Bousquet J, Casale T, et al. Sublin-
gual immunotherapy: World Allergy Organization
Position Paper 2009. World Allergy Organ J. 2009;
2:223–281.
5. Potter PC, Warner JO, Pawankar RS, et al; for the WAO
Specialty and Training Council. Recommendations
for competency in allergy training for undergraduates
qualifying as medical practitioners: A World Allergy
Organization Position Paper. World Allergy Organ J.
2009;2:150–189.
6. Kemp SF, Lockey RF, Simons FER; on behalf of the
World Allergy Organization ad hoc committee on epineph-
rine in anaphylaxis. Epinephrine: the drug of choice for
anaphylaxis. A Statement of the World Allergy Organiza-
tion. Allergy. 2008;63:1061–1070 and World Allergy
Organ J. 2008;1:S18–S26.
7. Pawankar RS, Baena-Cagnani CE, Bousquet J, et al. State
of World Allergy Report 2008: allergy and chronic respi-
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The congress in 2005 in Munich by all standards was
excellent. It was unusually hot in Munich in June 2005, and we
learned that few German hotels had functional air-conditioning.
I recall looking out my hotel window and inadvertently seeing
much more of the leadership of the world of allergy than was
seemly (through doors left open to try to cool the incredibly hot
rooms). The meeting was exceptionally well attended, with
more than 5000 attendingda record for WAO and for EAACI
at the time. With 3 societies (WAO, EAACI, and the German
Society of Allergology and Clinical Immunology) contributing
to the program, the meeting was very strong scientiﬁcally and
had wonderful venues for the social program.
Two more anecdotes: The awards ceremony was held at
a magniﬁcent palace in absolutely beautiful rooms. However,
there was no air-conditioning, and I recall presenting a very
special award to Barry Kay while drenched in sweat and not
wearing either a coat or a tie. In Europe, such informality,
especially in a royal palace, is unheard of! But, boy was it HOT!
The highlight of the meeting was the opera created by
Johannes Ring. He had served long and well on the WAO
Board. He was a Vice President, became the founding editor
of the newly launched World Allergy Organization Journal,
and was the Chair of the annual meeting in 2005 from the
German Society for Allergology and Clinical Immunology.
Johannes Ring is the rarely encountered “renaissance” man,
an astute academician, allergist-dermatologist, historian, and
semiprofessional composer of operas. I ﬁrst knew of his talent
at writing operas when 10 years earlier he had written an
homage to Alain deWeck, performed on a bus while we drove
through The Netherlands. The coup d’état in Munich was his
opera on allergy based upon Dante’s Inferno, written by
Johannes Ring and performed by his professional colleagues
in Munich. I treasure the recording of the performance and
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marvel at his talents and those of his colleagues. Of all of my
memories of memorable moments in WAO history over the
past 40 years, this one achieves a topmost tier.
All in all, it was a wonderful meeting and a ﬁtting end to
Carlos Baena-Cagnani’s tenure as president. Traditionally, the
WAO president’s term ends after his congress and the new
president assumes responsibility on the last day of the con-
gress. I was to follow him as the next president and was look-
ing forward to assuming the role. However, such was not to be
the case. At the Board meeting in the spring of 2005 just prior
to the Munich Congress, Richard Lockey ate lunch at a table
apart from my own. Richard Lockey is a wonderful Board
member, fully capable of making rapid and decisive decisions
and knowledgeable about how Boards operate. Well, after this
particular lunch, he immediately made a motion to have the
tenure of the president run from January 1 of the year following
our biennial Congress until December 31 of the next year. For
me, it cut 6 months from my possible term of presidency to
what is now the usual 2-year term as determined by the calen-
dar rather than the dates of the congress. In every way, the
decision to change the dates was correct, but I have made it
a policy to eat lunch with Richard Lockey at every Board
meeting since, just so I know what he might have up his sleeve.
Carlos Baena-Cagnani was an energetic WAO presi-
dent who took it upon himself to represent WAO in all
corners of the world. Some travel is a prerequisite of rep-
resenting WAO. He represented us well and everywhere. As
such, he became our diplomat and probably personally won
us as many friends as could be achieved in a 2-year period. I
have always recognized that Carlos Baena-Cagnani has more
best friends than anyone I have ever met. He is welcome
throughout the world because of his pleasant nature, charming
personality, and personal energy. Let me share one anecdote
about him: I arrived at a Board meeting having been able to
upgrade to business class because I had some (very limited)
status with this one airline. Lanny Rosenwasser ﬂew on the
same ﬂight, but in ﬁrst class, as he was a 100,000-mile trav-
eler. While getting our luggage, Walter Canonica (who was
President Elect at the time) arrived, and he related that he was
a 100,000-mile traveler with 2 airline systems. Finally, Carlos
Baena-Cagnani came sauntering over, having ﬂown in the
co-pilot’s seat, stating that he had 100,000-mile status with
3 separate airline systems. My hat is off to him. I appreciate
that he has earned the respect of allergists throughout the
world and that WAO has beneﬁted from his energy and will-
ingness to be our world diplomat.
2005–2010: PROGRESS ABOUNDS, WAO
ASCENDS, THE WORLD OF ALLERGY BENEFITS
My tenure as WAO President began in November 2005
and ran until December 31, 2007 (Fig. 10). By this time, I had
ofﬁcially been part of WAO since 1998, knew the organiza-
tion inside and out, and had previously directed a large orga-
nization by being president of the AAAAI in 1995–1996.
The WAO Executive Director, Stanley Mandarich, who per-
formed admirably while supporting Carlos Baena-Cagnani
during his presidency, decided to relocate. I was especially
privileged to be asked to work with Charu Malik, a wonderful,
astute, diplomatic (a skill in which I am woefully deﬁcient),
reliable, hardworking, and fun Executive Director. Charu and
I had a wonderful partnership during and after these 2 years.
She embodies the qualities that EDI provides to WAO: a de-
pendable colleague who always is supportive but steps up
when an error is about to be made. All the ofﬁcers of WAO
are volunteers who give up their time and energy for the
worthy purpose of assisting the world of allergy. Our EDI
colleagues are paid professionals who provide the 24/7 sup-
port that a thriving organization requires. Charu Malik,
Executive Director, along with Karen Henley Davies, Global
Projects Director, and Kay Whalen, Consulting Partner, have
earned the respect of all the members of WAO, and we are
indebted to them and to EDI.
I laid out my agenda for these 2 years in an editorial
published in Allergy and Clinical Immunology International
(ACII) in 2006 (Kaliner MA. A new direction for WAO and
ACII-JWAO. Journal of the World Allergy Organization.
2006:18). The following several paragraphs outline what
was proposed in 2005 and will be followed in more detail
by what actually occurred. The plan was to maintain 3 overall
principles: partnership, cooperation, and recognition. As a fed-
eration of allergy societies, the leadership of WAO was com-
mitted to partnering with member societies whenever
possible, cooperating with each other to strengthen each so-
ciety and always recognizing the skills and contributions that
each partner brings to any shared agenda.
Speciﬁc plans in 2005 were to develop the leadership
role of WAO by creating position papers that assist allergists
worldwide. It was during this period that the “Deﬁnition of an
FIGURE 10. Michael A. Kaliner, WAO President (2006–2007).
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Allergist” and the “Key Competencies” papers listed earlier
were created and published worldwide; these position papers
deﬁned the specialty and detailed the necessary skills and
training that are required to care for allergy patients. The start
of a number of fruitful programs that came into full develop-
ment over the next 6 years were initiated, including the 3 part
series on anaphylaxis, which has recently led to an authorita-
tive and extremely useful position paper on anaphylaxis,
headed by Estelle Simons.
The GLORIA program and the Seminars and Confer-
ences program were further developed and strengthened. The
American GLORIA program was developed and launched,
with more than 40 lectures delivered over the next few years.
WAF and other outreach programs were strengthened, as
one way to reduce WAO’s dependency on the income from the
biennial meeting. It was recognized that one cannot predict the
next SARS or Twin Towers disaster. Holding international
meetings is wrought with potential pitfalls; witness the current
upheaval in the Middle East and the earthquake and tsunami
in Japan early in 2011. Unpredictable geopolitical events are
capable of destroying the most well-planned meeting. The plan
developed in 2005 was to establish a network of partnerships
with global pharmaceutical companies, and to a large extent,
WAO was successful during that time frame. As mentioned
earlier, however, the world of pharmaceutical funding and
interactions between pharmaceutical companies and profes-
sional associations has changed dramatically, and we are cur-
rently back to largely depending on income generated by our
biannual meeting and a newly created interim meeting initially
held in Dubai, United Arab Emirates, in December 2010.
Richard Lockey, with the active assistance of Ruby Pawankar,
has developed this new concept, and the ﬁrst interim meeting
was very successful. More about this new development later.
During this period, support of the Emerging Societies
Program, in cooperation with the ACAAI, was strengthened,
and the number of ESP events expanded to 1–2 per year. The
WAO News and Notes electronic newsletter was increased in
frequency to monthly, and a set of discussions about the
creation of a new journal was initiated. The WAC in 2007
was held in Bangkok, Thailand, and was developed adhering
to the principles of welcoming partners from the various
allergy communities (Fig. 11). All in all, a challenging set
of plans was started, and this was a period when WAO grew
and strengthened considerably.
There were many individual areas of WAO that were
expanded and strengthened during these years, but the most
demanding and possibly the most important was the devel-
opment of a new WAO-owned journal, the World Allergy
Organization Journal. WAO had several publications span-
ning a several decade period, but none had been consis-
tently successful, either scientiﬁcally or ﬁnancially. In every
instance, WAO did not own the journal and had limited
responsibility for the direction and ﬁnancial issues related to
these journals. Allergy and Clinical Immunology News, or
ACIN (later Allergy and Clinical Immunology International)
was developed by Alain deWeck, who was the initial editor.
ACIN was designed to be a newsletter and was very readable
and quite an enjoyable magazine, but it was not scientiﬁcally
competitive. Attempts to get this journal into PubMed were
unsuccessful. The journal eventually became the Journal of
the World Allergy Organization, but this conversion was also
scientiﬁcally unsuccessful. Over the years, WAO had worked
closely with Hogrefe and Huber to develop a viable journal,
but in the period from 2005 to 2006, after a series of long and
difﬁcult discussions, WAO decided to part from Hogrefe and
Huber and establish its own journal. The concept of the new
journal was electronic, with rapid publication, an excellent
editorial board, a recognized publisher (Lippincott Williams
& Wilkins), and to be provided free to the readership. The
World Allergy Organization Journal has been promoted pri-
marily through the WAO e-mail list and all WAO meetings
and mailings. The ﬁrst editor was Johannes Ring, and he has
been succeeded by Lanny Rosenwasser. An initial attempt to
get accepted by PubMed has not been successful but attempts
are still proceeding. The ﬁrst few years of the World Allergy
Organization Journal have been promising, with some very
good articlesdboth scientiﬁc reviews and innovative new
sciencedbeing published. The initial costs are still affordable
to WAO, provided that there is a glimmer of success, as judged
by readership, citation index, and acceptance in PubMed.
The WAC held in Bangkok in December 2007 was
successful in a number of ways. The attendance was good
(4200 attendees from nearly 100 countries), the meeting was
proﬁtable ($260,000), and both the social and scientiﬁc
FIGURE 11. Logo of the XX World Allergy Congress, Bangkok,
Thailand, in 2007.
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aspects were excellent. The meeting was developed following
the principles of WAO interactions with its partners. The
Asthma, Allergy and Immunology Society of Thailand,
headed by Pakit Vichyanond, was involved in every decision
and directed the social aspects of the meeting. Pakit Vichya-
nond was an excellent host who represented the Eastern world
of allergy with grace and discretion. Pakit was a pleasure to
work with, and he made certain that there was an excellent
representation from Eastern speakers at the program. The
scientiﬁc program committee was headed by him, Anthony
Frew, and Lanny Rosenwasser, supported by Carlos Baena-
Cagnani and Walter Canonica. There were joint sessions
cohosted with AAAAI, ACAAI, and EAACI. These sessions
were part of focused “bookends” to anchor both the ﬁrst and
last days of the meeting. There was an aggressive movement
to showcase each member society by permitting “sister soci-
ety sessions” where WAO Member Societies individually
or in combinations of societies could sponsor a session, and
about 20 such society-sponsored sessions took place at
the meeting. There was a World Allergy Day held during
the congress, and an opportunity for member societies to have
an exhibit in the main portion of the registration area in a world
allergy village format. In partnership with Schering, APAACI
and EAACI, and a record number of travel grants were given
to nearly 100 young allergists. As part of the program, training
programs from around the world were given the opportunity to
compete with one another in an ongoing “Allergy Quiz,”
which ran throughout the entire meeting. Thus, the congress
in Thailand was innovative, entertaining, and completely suc-
cessful. As always, the science presented at the meeting was
a leading edge, the Thai settings were stupendous, and the
social program was memorable. I will always treasure the
feeling of being brought into the opening ceremony on a
palanquin carried by sturdy Thai men, led by beautiful Thai
women. Then, Pakit Vichyanond and I struck a large gong to
ofﬁcially open the meeting (Fig. 12). All in all, Thailand
proved to be a most hospitable host, Pakit Vichyanond and
the Asthma, Allergy and Immunology Society of Thailand
were gracious partners, and those allergists who attended the
meeting enjoyed themselves very well.
As a part of the promotion of WAC 2007, WAO held its
interim Board of Directors meeting in Korea in 2006, and most
members of the Board presented lectures as part of the annual
meeting of the Korean Academy of Allergy, Asthma and
Clinical Immunology. Thus, WAO held its Board meeting in
conjunction with the Academy’s annual meeting as a way to
support that society. Just prior to our visit to Korea, several
Board members also presented at the annual meeting of the
Japanese Society of Allergology. The idea to use the Board to
support member society meetings was novel and hopefully will
be continued into the future. In 2004 and 2007, WAO Board
members also supported our Afﬁliate Member, Interasma, at
their meetings in Bilbao, Spain, and Monaco, Monte Carlo.
Thus, WAO has also supported other organizations with lec-
turers. Along these same lines, the WAF program is part of the
AAAAI and EAACI annual programs with occasional presen-
tations at the ACAAI. The GLORIA lectures and the Seminars
and Conferences presentations always enhance WAO Member
Society meetings. These commitments reﬂect WAO’s contin-
ual effort to enhance the education of allergists worldwide.
During 2006, an agreement was made between WAO
and AAAAI to develop an extensive series of lectures on all
aspects of applied immunology and allergy and make them
available on the Web through both the AAAAI and WAO
Web sites. This extensive and excellent immunology series
is now online and provides an opportunity for worldwide
education. Parts of this program have been translated into
Japanese and Spanish.
WAO began an ambitious project focused on anaphy-
laxis in 2007, headed by Estelle Simons. This program
followed up on an earlier survey, which had identiﬁed the
dismally poor availability of injectable epinephrine in many
FIGURE 12. Michael Kaliner (WAO
President) and Pakit Vichyanond
(Congress Chair) during the Opening
Ceremony of the XX World Allergy
Congress, Bangkok, Thailand, 2007.
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countries. Under the excellent leadership of Estelle Simons,
2 additional surveys have been conducted and published,
demonstrating an improvement in the availability of allergy
services worldwide. These studies have highlighted the
importance of a proper diagnosis of anaphylaxis and its rapid
treatment. As a follow-up, a major WAO Position Paper
on anaphylaxis and a separate paper on the early use of
epinephrine in anaphylaxis have been published. This initia-
tive was initially sponsored by UCB.
During these 2 years, WAO solidiﬁed its position in the
world of allergy, continued its immense commitment to
global education in allergy (GLORIAdboth international
and US, Seminars and Conferences, WAF), held a very suc-
cessful congress in Thailand, supported its member societies
with several extremely important position papers designed to
strengthen the position of allergy in each country, and started
a new electronic journal. From my perspective as the presi-
dent, this was a very satisfying experience. The Board of
Directors of WAO with whom I worked included Walter
Canonica, Jean Bousquet, Ruby Pawankar, Richard Lockey,
and Carlos Baena-Cagnani, supported by Charu Malik, Karen
Henley, Katie Vande Zande, Jennie Smazik, Kate Kirchner,
and Kay Whalen from the Secretariat. I was extremely fortu-
nate to have such an accomplished Board with which to work,
and the achievements accomplished during that period reﬂect
enormous hard work and commitment (Fig. 13).
Walter Canonica became president at the completion
of WAC 2007 in Thailand (Fig. 14). As an esteemed
scientist with a worldwide reputation, and a powerful sup-
porting group in Genoa, Italy, he brought many skills to
the organization. One of his initial decisions was to
strengthen the WAO Mission Statement: WAO’s mission
is to be a global alliance and advocate in the ﬁeld of
allergy, advancing excellence in clinical care through
education, research, and training as a world-wide alliance
of allergy and clinical immunology societies.
Walter Canonica extended WAO’s usual committees
and councils with the development of a number of “special
committees,” as a way to involve more allergists in the WAO
and as a way to develop new initiatives. Thus, the usual WAO
committee structure consisting of audit and ﬁnance, awards,
bylaws, communication council, congress council, creden-
tials, education council, emerging societies, ethics, GLORIA,
research council, specialty, and training council, and WAF
was extended to include allergy diagnosis, anaphylaxis,
ARIA-GARD-WHO, asthma, clinical trials, evidence-based
medicine, food allergy, immunotherapy, and impact of cli-
mate change. I believe that Walter Canonica knew that not
every special committee would be functional, nor that all of
them would survive his tenure, but if some committees gen-
erated useful initiatives, that would sufﬁce.
Both the GLORIA and the Seminars and Conferences
committees were active through 2008, with multiple pro-
grams throughout the world and in the United States. The
Web site (www.worldallergy.org) continued to thrive with
tens of thousands of visitors, an active carefully selected
international editorial board; online learning and CME
modules; interactive modules on food allergy, parotitis, and
angioedema; a series of interviews with world experts on
a range of topics including (for example) Marek Kowalski
on Aspirin Exacerbated Respiratory Disease (AERD),
Thomas Casale on omalizumab, and Estelle Simons on epi-
nephrine, and a host of others; and an online allergic diseases
resource center where numerous educational synopses are
posted. The Web site was developed by Chief Editor, Richard
Lockey with support by many WAO members, the Web Ed-
itorial Board, and the WAO Secretariat. The current Editor-in-
Chief is Juan Carlos Ivancevich.
During 2006 and 2007, the Emerging Societies Program
had held meetings in Buenos Aires, Malaysia, Mexico, China,
and Bangkok; and in 2008, a major meeting was held for Latin
America in Venezuela. Ruby Pawankar raised the possibility of
FIGURE 13. Board of Directors 2006–
2007 during the XX World Allergy
Congress in Bangkok, Thailand.
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having an ESP meeting in Dubai in 2009 and also a World
Allergy Training School (WATS), as a part of the Middle East-
Asia Allergy Asthma Immunology Congress, and the Board
decided to support this idea. Both the ESP and the WATS in
2009 went extremely well. I have already mentioned the change
in pharmaceutical funding that developed in 2008–2009. WAO
recognized that GLORIA and other programs were not attract-
ing the funding awarded in earlier years and was forced to
restrict its budget to have sufﬁcient funding for essential pro-
grams. In fact, only 2 GLORIA presentations and 2 Seminars
and Conferences speakers were funded in 2009. Richard
Lockey and Ruby Pawankar initiated a proposal for an interim
meeting, held in the year between the biannual congresses, with
the initial meeting in Dubai, as a way to help bridge the ﬁnan-
cial gap. There were some Board members who were con-
cerned that an interim meeting might strain the Board, the
Secretariat support, and the pharmaceutical sponsors, but in
the end, Richard Lockey was given the chance to move forward
to explore this idea. He developed a proposal to hold a meeting
focused on asthma and its comorbidities as a way to attract not
only the usual allergy community but also primary care physi-
cians who deal with a broader spectrum of diseases.
As a leading scientist in the development of sublingual
immunotherapy, Walter Canonica proposed to gather the
world’s allergy societies and to develop a position statement
on the study of sublingual immunotherapy (SLIT). This meet-
ing was cohosted by most major allergy societies, such as
EAACI and AAAAI, and directed by Walter Canonica, and
it led to a publication summarizing the state of the art of sub-
lingual immunotherapy that also details the methods by which
SLIT and subcutaneous immunotherapy could be properly
studied as a way to make European and US studies more
compatible. “Sublingual Immunotherapy: World Allergy Orga-
nization Position Paper 2009” was published in the World
Allergy Organization Journal, while an accompanying Ros-
trum article, “Recommendations for appropriate sublingual im-
munotherapy trials” was published in the Journal of Allergy
and Clinical Immunology.
The Food Allergy Special Committee, headed by
Alessandro Fiocchi, developed an important paper on cow’s
milk allergy, published in the World Allergy Organization
Journal: “World Allergy Organization (WAO) Diagnosis and
Rationale for Action against Cow’s Milk Allergy (DRACMA)
Guidelines.”
Finally, a major endeavor was the development of
aWAOWhite Book on Allergy, headed by Ruby Pawankar,
and supported by Stephen Holgate, Richard Lockey, and
Walter Canonica (all 4 as editors) plus the WAO Board and
a worldwide group of allergists. This White Book succinctly
summarizes the state of the art of allergy and is designed as
a way to inﬂuence government decision makers when con-
sidering distribution of funds among various medical spec-
ialties. This project took 2 years to ﬁnalize, but it is an
extremely important publication, and it is available to anyone
on www.worldallergy.org. The White Book emphasizes the
importance of the specialty of allergy, the need for enhanced
medical teaching of allergic diseases, and the necessity to
provide specialized treatment for the tens of millions of
allergy sufferers worldwide.
In 2009, the Specialty and Training Council produced
another position paper on Undergraduate Training in Allergy:
“Recommendations for Competency in Allergy Training for
Undergraduates Qualifying as Medical Practitioners: A World
Allergy Organization Position Paper,” and was published in
World Allergy Organization Journal and is also available on
www.worldallergy.org.
By 2010, the membership in WAO had grown to 83
member societies. ESP meetings were held in Dubai, Warsaw,
and Vietnam.
The culmination of Walter Canonica’s presidency was
the WAC in Buenos Aires (WAC 2009), chaired by his close
friend Carlos Baena-Cagnani. This was the second meeting
in Argentina; the ﬁrst was held in 1979 and was a ﬁnancial
disaster. The second Buenos Aires meeting was quite success-
ful, with more than 5000 attending, excellent science, and
an altogether pleasant experience. Unfortunately, this meeting
was also a ﬁnancial disaster, with a net proﬁt of less
than $100,000. It is hard to explain the reasons why a well-
attended meeting could be nonproﬁtable, and even from
a clear retrospective analysis, it is still not clear what
happened. Certainly, Argentina turned out to be quite exp-
ensive, the social programs were outstanding but were far too
expensive, and the government taxed the revenue despite
promises that they would not. The primary lesson learned
was that WAO cannot allow meetings to proceed without
ironclad control of all expenditures and total control of all
the ﬁnances. Having said that, I believe that these lessons
were learned and that they will be instituted henceforth.
WAC 2009 in Buenos Aires was a lovely meeting and won
WAO many worldwide admirers and supporters.
FIGURE 14. Giorgio Walter Canonica, WAO President (2008–
2009).
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2010 AND THE FUTURE. TOWARD PROVIDING
EXPERT CARE FOR MILLIONS OF
PATIENTS WORLDWIDE
Richard Lockey became president on January 1, 2010,
recognizing that WAC 2009 in Buenos Aires had left him
with markedly depleted funds for his 2-year term (Fig. 15).
He, and the Executive Committee, decided to move forward
with an interim meeting late in 2010 focused on diseases,
which overlap and inﬂuence the course of asthma. Dubai,
United Arab Emirates, was the site, and the meeting was
focused on the Middle East. About 1400 attended the meet-
ing, which was run on a very tight budget and with adequate
pharmaceutical support. The meeting was extremely success-
ful from the scientiﬁc and ﬁnancial aspects with a proﬁt of
more than $300,000. The credit for this successful meeting
goes to Richard Lockey, Ruby Pawankar, and the rest of the
Board of Directors. The drive, organizational skills, and fore-
sight to create such a meeting deﬁne the type of leadership
now in control of WAO. The organization is being run in an
extremely transparent democratic fashion, with multiple
Board members having responsibility for multiple aspects
of the organization. When I think back 2 decades to the
“Old Boy’s Club” that existed until 2000, compared with
the dynamic global structure currently in place, I feel
extremely pleased that the world of allergy is being led by
this organization. Richard Lockey joins the group of outstand-
ing leaders who have left a permanent imprint on the organi-
zation. He has been the driving force behind the constitution
and the Web site, and he has impacted WAO’s ﬁnances
repeatedly. He has insisted on a democratic structure, run with
the highest standards of ethics, and has asked everyone to
contribute their time and energy. He will have the chance to
contribute his own chapter to this history, but my expectation
is that he will be much too modest to describe his achieve-
ments in the terms I have chosen.
In 2012–2013, the president will be Ruby Pawankar, an
Indian, based in Japan. She joined the WAO Board in January
2001 and has served as Treasurer and President-Elect. She
will run the 2nd WAO International Scientiﬁc Conference in
India, December 2012. As WAO President, she will co-chair
with EAACI President Cezmi Akdis the World Allergy
Congress in June 2013 to be held jointly with the EAACI
Congress in Italy. Lanny Rosenwasser will be president in
2014–2015, and he will chair the Congress in 2015 in South
Korea. The venue for the Congress in 2017 will be chosen
during WAC 2011 in Cancun.
As I look at the activity currently being invested in
WAO and the world of allergy, I cannot but be impressed
with the scope of activity underway. All aspects of allergy are
being explored, with research papers, position statements,
congresses, lectures, webinars, and the like providing the
world with great opportunities for education. The Web site
continues to grow and strengthen under the leadership of Juan
Carlos Ivancevich. The World Allergy Organization Journal
is being run by Lanny Rosenasser with the assistance of
a worldwide selection of allergy leaders. The WAC 2011 in
Cancun is headed by Richard Lockey, but Thomas Casale is
organizing the program.
I see activity for WAO from many Europeans, Africans,
Asians, North Americans, and Latin Americans. The diversity
of those actively participating is exactly what we had in mind
in 1998 when the IAACI retreat in Sweden took place. That
such an exhilarating achievement has been created, has
taken roots, and has developed in this decade of activity is
breathtaking. From those of us who have been privileged to
watch WAO develop, to those of you who will participate in
an even stronger organization in the future, we all must
recognize that the hundreds of millions of allergy and asthma
sufferers are the real beneﬁciaries of this work. The medical
specialty of allergy has been strengthened by WAO, but it is
the patients who will beneﬁt. Patients who already have
access to well-trained specialists will ﬁnd these physicians
better trained and those patients whose access will be
available only because WAO laid the groundwork for their
physicians to receive training in allergy may not understand
the role WAO played but will beneﬁt by the availability of
a specialist speciﬁcally trained to treat them. It is the com-
mitment to global education, to convincing governments that
allergy needs to be supported and fostered, and the seminal
work of developing allergy societies that exempliﬁes what
WAO has and will contribute to the world of allergy.
For me, my small contributions to WAO and the world
of allergy have been the highlights of a successful career. It has
been my privilege to work with giants such as de Alain
deWeck, Jack Pepys, Terumasa Miyamoto, Gunnar Johansson,
Allen Kaplan, Walter Canonica, Richard Lockey, Stephen
Holgate, Marek Kowalski, and so many others. It is easy to see
how the time and energy devoted to WAO have led to
achievements not otherwise possible and to encourage others
to invest their time and skills to future achievements.
FIGURE 15. Richard F. Lockey, WAO President (2010–2011).
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